EMA closed 1 May

Information and Q&A session on updated CAPs in web-based eAF, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 May 2024, 10:00 (CEST) to 7 May 2024, 11:00 (CEST)

Enpr-EMA Coordinating Group meeting March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 March 2024, 15:30 (CET) to 4 March 2024, 17:00 (CET)

Committee for Advanced Therapies (CAT): 13-15 March 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2024 to 15 March 2024

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 15, Status: Authorised

Organisation chart of the European Medicines Agency

Guidance on good manufacturing practice and good distribution practice: Questions and answers

Development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisations

Scientific guidelines for veterinary medicines